Henry Schein (NASDAQ:HSIC) Updates FY 2026 Earnings Guidance

Henry Schein (NASDAQ:HSIC) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 5.290-5.390 for the period, compared to the consensus EPS estimate of 5.340. The company issued revenue guidance of $13.8 billion-$13.9 billion, compared to the consensus revenue estimate of $13.7 billion.

Analysts Set New Price Targets

A number of research firms have commented on HSIC. Citigroup reiterated a “buy” rating and set a $112.00 target price (up from $100.00) on shares of Henry Schein in a research report on Wednesday. Barclays reaffirmed an “overweight” rating and set a $100.00 price target (up from $86.00) on shares of Henry Schein in a research note on Thursday. BMO Capital Markets assumed coverage on shares of Henry Schein in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $85.00 price objective on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Henry Schein in a research note on Friday, July 31st. Finally, BTIG Research restated a “buy” rating and set a $100.00 target price on shares of Henry Schein in a report on Wednesday. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $92.27.

Henry Schein Trading Down 1.3%

HSIC stock traded down $1.13 during midday trading on Thursday, hitting $88.46. The stock had a trading volume of 300,552 shares, compared to its average volume of 1,398,399. The firm has a market cap of $10.08 billion, a PE ratio of 25.83, a price-to-earnings-growth ratio of 1.70 and a beta of 0.80. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.75. Henry Schein has a 12-month low of $61.94 and a 12-month high of $92.18. The company’s 50-day moving average price is $83.02 and its 200 day moving average price is $78.55.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.03. The company had revenue of $3.46 billion for the quarter, compared to analyst estimates of $3.37 billion. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.10 EPS. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. On average, equities research analysts predict that Henry Schein will post 5.34 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director William K. Daniel acquired 10,000 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $69.19 per share, with a total value of $691,900.00. Following the purchase, the director directly owned 20,000 shares in the company, valued at $1,383,800. The trade was a 100.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.89% of the stock is owned by company insiders.

Hedge Funds Weigh In On Henry Schein

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Squarepoint Ops LLC purchased a new position in shares of Henry Schein in the 4th quarter worth $202,000. Sargent Investment Group LLC purchased a new stake in Henry Schein during the fourth quarter valued at about $214,000. Davis R M Inc. acquired a new stake in Henry Schein during the fourth quarter worth about $219,000. Mitchell Mcleod Pugh & Williams Inc. acquired a new stake in Henry Schein during the fourth quarter worth about $200,000. Finally, CIBC Private Wealth Group LLC raised its holdings in shares of Henry Schein by 125.1% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 3,260 shares of the company’s stock worth $216,000 after purchasing an additional 1,812 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.